RPE65 and Leber congenital amaurosis: Luxturna is a novel gene therapy medication used to treat a specific form of inherited retinal disease called Leber congenital amaurosis (LCA) or retinitis pigmentosa (RP) caused by mutations in the RPE65 gene [11].